Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Apr 17 2025

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-apr-17-2025-11

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 17, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Carbamazepine Tablets USP, 200 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases